Melagatran/ximelagatran versus enoxaparin for the prevention of venous thromboembolic events - EXTEND

Inclusion Criteria

• Inclusion Criteria:
• - Signed informed consent,
• - Female or male aged 18 years and over
• - Patient scheduled for primary elective hip replacement or patient requiring surgery for hip fracture.
• Exclusion Criteria:
• - History of heparin-induced thrombocytopenia
• - Conditions associated with increased risk of bleeding, renal impairment, known active liver disease or liver insufficiency.
• - Myocardial infarction, Ischemic stroke or Transient Ischemic Attack (TIA), systemic embolism or venous thrombo-embolism within 30 days of enrollment.